Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail

NCT ID: NCT02159417

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A lot of data show that therapeutic education is beneficial for diabetic patients. In the French jails, there are very few programs of therapeutic education while this population is usually precarious with no access at care sector before the jail.

The purpose of this study is to determinate if the therapeutic education of the diabetic patients is possible in the Paris jail "La Santé".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Paris jail "La Santé" welcomes 600 men who stay 5 month on average. Each year, there are between 30 to 40 diabetic patients. In the jail there's a sanitary unit who is a unit of internal medicine of Cochin hospital. This unit includes nurses, pharmacists and medical doctors.

We propose to include in this study all diabetic patients (type 1 and 2) with the realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic (knowledge of the disease, food, physical Activity and care of feet, the therapeutics)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 or 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Therapeutic Education

Intensive training individual or collective teaching

Group Type EXPERIMENTAL

Therapeutic Education

Intervention Type OTHER

Realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic:

* Knowledge of the disease
* Food
* Physical Activity and care of feet
* The therapeutics

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapeutic Education

Realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic:

* Knowledge of the disease
* Food
* Physical Activity and care of feet
* The therapeutics

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intensive training individual and collective teaching

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patient detained in the MAPLS of more than 18 years
* Patient prisoner in the MAPLS for more than 15 days
* Patient follow-up for a diabetes of type 1 or type 2
* Patient informed about the study and not having opposed to this one
* Patient taken out of the disciplinary district which had previously been included for this motive

Exclusion Criteria

* Patient considered incapable by the investigator to follow an ETP program
* Patient having a bad understanding of the spoken French language
* Patient whose duration of confinement known about the MAPLS is strictly lower than 1 month in the inclusion during the year 2013/2014
* Patient prisoner in the district of isolation
* Patient prisoner in the disciplinary district in the inclusion
* Patient prohibition to communicate with another prisoner already registered on the session to come
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

URC-CIC Paris Descartes Necker Cochin

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin SILBERMANN, MD, PhD

Role: STUDY_DIRECTOR

Assistance Publique - Hôpitaux de Paris

Laura HARCOUET, Pharm D

Role: STUDY_DIRECTOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital COCHIN

Paris, , France

Site Status

Maison d'Arrêt Paris La Santé (MAPLS)

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A00704-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Internet Diabetes Self-Management
NCT00372463 COMPLETED PHASE2